The most commonly used method of emergency
contraception today is the Yuzpe regimen, which was developed some 25
years ago. It basically involves taking an increased dose of an oral
contraceptive and it has been called the "morning after pill".
An initial dose of two pills comprising 100 µg ethinylestradiol plus 500
µg levonorgestrel, or 1 mg dl-norgestrel, is followed 12 hours later by a
dose of two more pills. Traditionally it has been recommended that the
first dose of pills is taken within 72 hours of an act of unprotected
intercourse.
Until recently, the Yuzpe regimen of combined oral
contraceptive pills has been the only hormonal method available for
emergency contraception. It prevents about 75% of pregnancies that would
otherwise be expected to occur: approximately 8% of women can be expected
to become pregnant after a single act of unprotected intercourse on a
random day of the menstrual cycle, but only about 2% become pregnant if
they use the Yuzpe regimen.
An alternative and more effective method is the
insertion of a copper intrauterine device (IUD) by a trained service
provider. If inserted within five days of unprotected sexual intercourse,
the copper IUD prevents pregnancy in 99% of cases.
Neither of these methods is fully satisfactory for
emergency contraception, however. As noted above, the Yuzpe regimen fails
to prevent about one-quarter of the pregnancies that would be expected to
occur following unprotected sexual intercourse. It can also cause
unpleasant side-effects: nausea, vomiting, headaches and dizziness are
regularly reported by women who have used the regimen.
Emergency contraceptive pills are intended as just
that—i.e. for one-time use in emergencies. Indeed, if a woman uses
emergency contraceptive pills frequently, her cumulative risk of pregnancy
is higher than if she consistently used oral contraceptives, an IUD
or barrier methods.
On the other hand, the copper IUD, while certainly
effective as a method of emergency contraception, has a certain number of
drawbacks. The IUD is usually not recommended for use by young women who
have not yet had children, yet it is precisely this group of women who
constitute a large proportion of those requesting emergency contraception.
The IUD is also unsuitable as a contraceptive method for women at risk of
sexually transmitted diseases unless they use an additional barrier
method. The IUD use is generally not recommended for women whose pregnancy
status is unclear—such as in women who may be pregnant as a result of an
earlier act of unprotected sexual intercourse—as IUD insertion in a
woman with established pregnancy can lead to serious complications.
The Yuzpe method of emergency contraception works by
interrupting a woman's reproductive cycle. Depending on when in the cycle
the pills are taken, they can prevent or delay ovulation, may interfere
with fertilization of the egg, or block implantation in the uterus wall.
Medical science considers that pregnancy has begun when the implantation
of a fertilized egg in the lining of a woman's uterus is complete. The
process of implantation starts about five days after fertilization and is
completed about one week later, just prior to the time of the expected
menses. Emergency contraceptive pills are ineffective after implantation;
they cannot cause an abortion if the woman is already pregnant.
The Programme has been in the forefront of research on
new methods for emergency contraception for the past 10 years and has been
investigating two compounds, levonorgestrel and mifepristone, for this
purpose. The next two articles summarize the findings of two recent
multicentre research projects on the effectiveness and side-effects of
these two compounds.